# FDA recall D-887-2013

> **Hospira Inc.** · Class II · drug recall initiated 2013-05-25.

## Product

Propofol Injectable Emulsion, 1%, 1 g/100 mL (10 mg/mL), 100 mL, Single patient infusion vial, RX only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-24; Propofol Injectable Emulsion, 500 mg/50 mL, 50 mL, Single patient infusion vial, RX only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-33

## Reason for recall

Presence of Particulate Matter; single visible particulate was identified during a retain sample inspection identified as stainless steel

## Distribution

Nationwide

## Key facts

- **Recall number:** D-887-2013
- **Recalling firm:** Hospira Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-05-25
- **Report date:** 2013-08-21
- **Termination date:** 2014-09-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-887-2013

## Citation

> AI Analytics. FDA recall D-887-2013. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-887-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*